DaVita DVA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
DaVita (DVA) Business Model and Operations Summary
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Key Insights
DaVita (DVA) Core Market Data and Business Metrics
Latest Closing Price
$151.91Market Cap
$13.37 BillionPrice-Earnings Ratio
14.16Total Outstanding Shares
87.70 Million SharesTotal Employees
70,000Dividend
No dividendIPO Date
October 31, 1995SIC Description
Services-misc Health & Allied Services, NecPrimary Exchange
New York Stock ExchangeHeadquarters
2000 16th Street, Denver, CO, 80202
Historical Stock Splits
If you bought 1 share of DVA before June 16, 2004, you'd have 3 shares today.
| Execution Date | Split Amount |
|---|---|
| September 9, 2013 | 2-for-1 |
| June 16, 2004 | 3-for-2 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-771.43 Million |
| Net Cash Flow From Financing Activities, Continuing | $-816.94 Million |
| Net Cash Flow From Financing Activities | $-816.94 Million |
| Net Cash Flow From Investing Activities, Continuing | $-771.43 Million |
| Net Cash Flow, Continuing | $433.67 Million |
| Net Cash Flow | $433.67 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Net Income/Loss Attributable To Noncontrolling Interest | $314.39 Million |
| Operating Expenses | $10.73 Billion |
| Income/Loss From Continuing Operations Before Tax | $1.53 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $936.34 Million |
| Basic Earnings Per Share | $11.02 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $314.39 Million |
| Other Comprehensive Income/Loss | $-258.71 Million |
| Comprehensive Income/Loss | $992.02 Million |
| Comprehensive Income/Loss Attributable To Parent | $677.63 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $17.29 Billion |
| Noncurrent Assets | $13.54 Billion |
| Other Current Liabilities | $1.63 Billion |
| Current Liabilities | $2.97 Billion |
| Other Non-current Assets | $10.40 Billion |
| Liabilities | $15.19 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||